Search Results

ML329 2 mg  | Purity Not Available

TargetMol

ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.

More Information Supplier Page

QS11 25 mg  | 98.39%

TargetMol

QS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.

More Information Supplier Page

QS11 2 mg  | 98.39%

TargetMol

QS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.

More Information Supplier Page

Relebactam 10 mg  | Purity Not Available

TargetMol

Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases.

More Information Supplier Page

BTZ043 25 mg  | 99.69%

TargetMol

BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.

More Information Supplier Page

SCH900776 (S-isomer) 2 mg  | 99.95%

TargetMol

SCH900776 S-isomer (MK-8776 S-isomer) is an effective, specific and orally bioavailable inhibitor of checkpoint kinase Chk1 (IC50: 3 nM). It also inhibitors Chk2 (IC50: 1500 nM) and cyclin-dependent kinase CDK2 (IC50: 160 nM).

More Information Supplier Page

K-Ras(G12C) Inhibitor 6 2 mg  | 100.00%

TargetMol

K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro.

More Information Supplier Page